Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients (Q37299042)

19 August 2017

Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients (English)

1 reference

19 August 2017

0 references

hepatocellular carcinoma

1 reference

B Li

1

1 reference

19 August 2017

H Liu

2

1 reference

19 August 2017

H W Shang

3

1 reference

19 August 2017

P Li

4

1 reference

19 August 2017

N Li

5

1 reference

19 August 2017

H G Ding

6

1 reference

19 August 2017

1 September 2013

1 reference

19 August 2017

African Health Sciences

1 reference

19 August 2017

13

1 reference

19 August 2017

3

1 reference

19 August 2017

703-709

1 reference

MiR‐219‐5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican‐3

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

General Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Hepatocellular carcinoma: diagnosis and treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Glypicans: proteoglycans with a surprise

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3824453

Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients

2 September 2018

1 reference

12 December 2020

Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: A tissue microarray-based study

1 reference

12 December 2020

Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma

1 reference

12 December 2020

The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas

1 reference

12 December 2020

Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples

1 reference

12 December 2020

Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology

1 reference

12 December 2020

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

1 reference

12 December 2020

Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics

1 reference

12 December 2020

Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules

1 reference

12 December 2020

Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis

1 reference

12 December 2020

Identifiers

DOI

10.4314/AHS.V13I3.26

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

24250310

1 reference